GlassScriptPhysician profile
Jason B Karp
NPI 1376514265
$11,128.32
in general payments reported to CMS, 2019-2025
26 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,612 · 2020: $1,593 · 2021: $879 · 2022: $978 · 2023: $899 · 2024: $996 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,966 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,966.32 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $4,000.63 | 2019-2025 | Nucala |
| Jazz Pharmaceuticals INC. | $1,050.00 | 2020 | |
| Insmed, INC. | $928.27 | 2019 | |
| Amgen INC. | $721.05 | 2021-2025 | Tezspire |
| Astrazeneca Pharmaceuticals LP | $675.88 | 2021-2025 | Fasenra |
| Philips North America LLC | $569.46 | 2020-2024 | (Ak6) Vest Therapy |
| Actelion Pharmaceuticals US, INC. | $543.48 | 2020-2025 | Uptravi, Opsynvi |
| Regeneron Pharmaceuticals, INC. | $404.85 | 2023-2025 | Dupixent |
| Regeneron Healthcare Solutions, INC. | $371.49 | 2019-2025 | Dupixent |
| Inspire Medical Systems, INC. | $286.57 | 2022-2024 | Inspire |
| Genzyme Corporation | $276.91 | 2019-2025 | |
| Ventec Life Systems, INC. | $220.22 | 2020 | |
| Genentech USA, INC. | $199.88 | 2019-2023 | Xolair |
| United Therapeutics Corporation | $140.00 | 2020-2021 | |
| 3b Medical, INC. | $134.64 | 2024 | Luna |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $130.21 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Olympus America INC. | $124.99 | 2022 | |
| Mallinckrodt Hospital Products INC. | $123.51 | 2021-2023 | Acthar |
| Intuitive Surgical, INC. | $72.36 | 2025 | |
| Medtronic, INC. | $50.00 | 2021 | |
| Genentech, INC. | $33.06 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.43 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2019 | |
| Hikma Pharmaceuticals USA | $14.81 | 2023 | Ryaltris |
| Pfizer INC. | $11.41 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Karp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.